These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28222529)

  • 1. Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein.
    Yin Z; Valkenburg F; Hornix BE; Mantingh-Otter I; Zhou X; Mari M; Reggiori F; Van Dam D; Eggen BJL; De Deyn PP; Boddeke E
    J Alzheimers Dis; 2017; 60(s1):S41-S57. PubMed ID: 28222529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor deficit in a tauopathy model is induced by disturbances of axonal transport leading to dying-back degeneration and denervation of neuromuscular junctions.
    Audouard E; Van Hees L; Suain V; Yilmaz Z; Poncelet L; Leroy K; Brion JP
    Am J Pathol; 2015 Oct; 185(10):2685-97. PubMed ID: 26272360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW
    J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.
    Miller N; Feng Z; Edens BM; Yang B; Shi H; Sze CC; Hong BT; Su SC; Cantu JA; Topczewski J; Crawford TO; Ko CP; Sumner CJ; Ma L; Ma YC
    J Neurosci; 2015 Apr; 35(15):6038-50. PubMed ID: 25878277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
    Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
    Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral nervous system effects in the PS19 tau transgenic mouse model of tauopathy.
    Merchán-Rubira J; Sebastián-Serrano Á; Díaz-Hernández M; Avila J; Hernández F
    Neurosci Lett; 2019 Apr; 698():204-208. PubMed ID: 30677432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration.
    Adams SJ; Crook RJ; Deture M; Randle SJ; Innes AE; Yu XZ; Lin WL; Dugger BN; McBride M; Hutton M; Dickson DW; McGowan E
    Am J Pathol; 2009 Oct; 175(4):1598-609. PubMed ID: 19717642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.
    van Eersel J; Stevens CH; Przybyla M; Gladbach A; Stefanoska K; Chan CK; Ong WY; Hodges JR; Sutherland GT; Kril JJ; Abramowski D; Staufenbiel M; Halliday GM; Ittner LM
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):906-25. PubMed ID: 25763777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
    Wade A; Jacobs P; Morton AJ
    Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
    Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
    J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated sarcopenia precedes learning and memory impairments in the P301S mouse model of tauopathies and Alzheimer's disease.
    Longo S; Messi ML; Wang ZM; Meeker W; Delbono O
    J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1358-1375. PubMed ID: 38646816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for dying-back axonal degeneration in age-associated skeletal muscle decline.
    Chung T; Park JS; Kim S; Montes N; Walston J; Höke A
    Muscle Nerve; 2017 Jun; 55(6):894-901. PubMed ID: 27464347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
    Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X
    J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.
    Xu H; Rösler TW; Carlsson T; de Andrade A; Bruch J; Höllerhage M; Oertel WH; Höglinger GU
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):833-43. PubMed ID: 24865638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cre-inducible Adeno Associated Virus-mediated Expression of P301L Mutant Tau Causes Motor Deficits and Neuronal Degeneration in the Substantia Nigra.
    You Y; Botros MB; Enoo AAV; Bockmiller A; Herron S; Delpech JC; Ikezu T
    Neuroscience; 2019 Dec; 422():65-74. PubMed ID: 31689387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
    Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
    Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.